Medical Properties
MPT

Medical Properties (MPT) earnings history

Most recent quarter

Period end
Jun 30, 2026
EPS actual
−$0.01
EPS surprise
−312.77%
Revenue
$259.3M
Reported
Aug 10, 2026

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q2 2026Aug 10, 2026$0.00−$0.01−312.77%$259.3MSEC
Q1 2026Apr 30, 2026$0.03$0.05+81.82%$252.1MSEC
Q4 2025Feb 19, 2026$0.01$0.03+130.77%$270.3MSEC
Q3 2025Oct 30, 2025$0.01−$0.13−1201.69%$237.5MSEC
Q2 2025Jul 31, 2025−$0.00−$0.16−11328.57%$240.4MSEC
Q1 2025May 1, 2025$0.01−$0.20−1969.16%$223.8MSEC
Q4 2024Feb 27, 2025−$0.06−$0.69−1089.66%$231.8MSEC
Q3 2024Nov 7, 2024$0.02−$1.34−5614.40%$225.8MSEC
Q2 2024Aug 8, 2024$0.04−$0.54−1313.48%$266.6MSEC
Q1 2024May 9, 2024$0.09−$1.23−1468.19%$271.3MSEC
Q4 2023Feb 21, 2024$0.15−$1.11−860.80%−$122.4MSEC
Q3 2023Oct 26, 2023$0.19$0.19−0.78%$306.6MSEC
Q2 2023Aug 8, 2023$0.22−$0.07−132.15%$337.4MSEC
Q1 2023Apr 27, 2023$0.22$0.05−77.53%$350.2MSEC
Q4 2022Feb 23, 2023$0.27−$0.24−187.56%$380.5MSEC
Q3 2022Oct 27, 2022$0.30$0.37+22.76%$352.3MSEC
Q2 2022Aug 3, 2022$0.30$0.32+8.29%$400.2MSEC
Q1 2022Apr 28, 2022$0.31$1.05+243.70%$409.8MSEC
Q4 2021Feb 3, 2022$0.31$0.34+9.43%$409.3MSEC
Q3 2021Oct 28, 2021$0.28$0.29+2.91%$390.8MSEC

Quarterly revenue

Q3 2021
$390.8M
Q4 2021
$409.3M
Q1 2022
$409.8M
Q2 2022
$400.2M
Q3 2022
$352.3M
Q4 2022
$380.5M
Q1 2023
$350.2M
Q2 2023
$337.4M
Q3 2023
$306.6M
Q4 2023
−$122.4M
Q1 2024
$271.3M
Q2 2024
$266.6M
Q3 2024
$225.8M
Q4 2024
$231.8M
Q1 2025
$223.8M
Q2 2025
$240.4M
Q3 2025
$237.5M
Q4 2025
$270.3M
Q1 2026
$252.1M
Q2 2026
$259.3M

Frequently asked questions

  • When did Medical Properties (MPT) last report earnings?

    Medical Properties last reported on Aug 10, 2026, covering fiscal Q2 2026.

  • Did MPT beat earnings estimates?

    No. Medical Properties reported EPS of −$0.01 for Q2 2026 against a $0.00 estimate — a 312.77% miss.

  • How much revenue did MPT report last quarter?

    Medical Properties reported $259.3M in revenue for Q2 2026, against a consensus estimate of $247.3M.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.